Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Monday, April 9, 2007
Today's Globe: anti-anemia drug roadblocks, AIDS orphans, bed sores, new hepatitis drug
A licensing deal between Beth Israel Deaconess Medical Center and a Florida biotechnology company to produce a "super" form of an anti-anemia drug is in danger of foundering just two years after it was signed.
As the creator of the first global center dedicated exclusively to health and human rights, at the Harvard School of Public Health, Countess Albina du Boisrouvray probably has as much hands-on experience in both as anyone. She's adopted the world's AIDS orphans as her cause.
Until recently, most experts believed that bed sores were an unambiguous indicator of bad care.
In Business & Innovation, for Vertex Pharmaceuticals Inc., the future hinges on a potential billion-dollar drug for hepatitis C and a liver-research conference about to kick off 3,700 miles away in Spain where it will unveil new data from human trials of the pill.